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Objective: Most studies recommend repair of renal artery aneurysms (RAAs) >2 cm in diameter in asymptomatic patients,
but other studies have suggested that their natural history may be more benign. We hypothesized that rupture and death
in patients with asymptomatic RAAs is low and that current recommendations for RAA treatment at 2 cm may be too
aggressive.
Methods: Retrospective review of all RAAs treated at a tertiary care medical center from 2002 to 2012.
Results: Fifty-nine RAA were identiﬁed in 40 patients (mean age at diagnosis, 56 years; male:female ratio, 17:23); 31 were
saccular, 8 were fusiform, and 5 were bilobed. Twenty-nine patients were asymptomatic; the remainder of patients
presented with hematuria (n[ 4), abdominal pain (n[ 3), difﬁcult-to-control hypertension (n[ 3), or ﬂank pain (n[
2). Aneurysm location included the main renal artery bifurcation (n[ 35), main trunk (n[ 7), primary branch (n[ 6),
pole artery (n [ 6), and secondary branch (n [ 1). Operative management of RAAs included vein patch (n [ 6),
prosthetic patch (n[ 4), primary repair (n [ 3), plication (n [ 1), patch and implantation (n [ 1), and ex vivo repair
(n [ 1). Eight asymptomatic RAAs were treated surgically (mean RAA diameter [ 2.4 6 0.1 cm, range, 2-3 cm), with
the remaining 33 asymptomatic RAAs being managed conservatively (mean RAA diameter [ 1.4 6 0.1 cm, range, 0.6-
2.6 cm). Mean hospital length of stay was 4 days, with no late postoperative complications and 0% mortality. Non-
operated patients were followed for a mean of 36 6 9 months, with no late acute complications and 0% mortality.
Mean RAA growth rate of patients with multiple imaging studies was 0.60 6 0.16 mm/y.
Conclusions: The rate of aneurysm rupture and death in our untreated RAA patients is zero, the growth rate is 0.60 6
0.16 mm/y, and there were no adverse outcomes in asymptomatic RAAs >2 cm that were observed. We may currently be
too aggressive in treating asymptomatic RAAs. (J Vasc Surg 2014;59:1356-61.)Renal artery aneurysms (RAAs) are uncommon, with
an estimated incidence of 0.09%1; however, the increased
use of cross-sectional abdominal imaging techniques such
as computed tomography and magnetic resonance imaging
has resulted in an increased frequency of incidentally discov-
ered RAAs.1-3 The current recommendation to repair all
asymptomaticRAAs>2 cm in diameter has led to an increase
in RAA procedures,1-3 but there remains signiﬁcant contro-
versy surrounding these treatment criteria.4,5
Because of the rarity of RAA rupture, the natural his-
tory is not well deﬁned, but the risk of rupture is thought
to be <3% of diagnosed RAAs.4 Both the rate of rupture
and the growth rate of RAAs have yet to be precisely deter-
mined.4 Furthermore, many authors dispute the concept
that aneurysm size and risk of rupture are directly corre-
lated, because studies have shown that aneurysms <2 cmthe Division of Vascular Surgery, University of California Los
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6rupture and aneurysms >2 cm may remain clinically silent
for years.1,6-8 Although there is consensus to repair RAAs
in symptomatic patients and in women who are pregnant
or of childbearing age because of the risk of rupture, the
appropriate management of asymptomatic RAAs remains
unclear.
The objectives of our study were to (1) examine our
institution’s experience with RAAs, with speciﬁc emphasis
on the long-term outcome of asymptomatic RAAs, (2)
measure the growth rate of asymptomatic RAAs, and
(3) evaluate the contemporary validity of current treat-
ment recommendations.
METHODS
Patients presenting to the University of California Los
Angeles (UCLA) Division of Vascular Surgery and UCLA
medical center with true RAAs between 2002 to 2012
were identiﬁed through the use of ICD-9 disease codes
442.1 (aneurysm of renal artery) and 442.89 (aneurysm
of other speciﬁed artery). Patients presenting with both
symptomatic and asymptomatic RAAs were included in
this analysis. Symptomatic RAAs were deﬁned through the
use of previously published criteria, including: difﬁcult-to-
control hypertension, hematuria, ﬂank pain, and/or abdom-
inal pain.1 Symptomswere attributed to the aneurysm if they
resolved after surgery or if no other etiology was discovered.
Sources used to identify isolated RAA included: medical
records, imaging studies, and pathology reports. Pseudo-
aneurysms, mycotic aneurysms, pararenal and juxtarenal
aortic aneurysms, and aneurysms of the proximal renal artery










Abdominal pain 3 8
Difﬁcult-to-control hypertension 3 8
Flank pain 2 5
Comorbidities
Hypertension 26 65
Diabetes mellitus 14 35
Smoking 8 20
Hypercholesterolemia 3 8
Coronary artery disease 3 8






(n ¼ 59) P value
Laterality NS
Right 24 10 34
Left 18 6 24
Location NS
Main bifurcation 26 9 35
Main trunk 5 2 7
Primary branch 4 2 6
Pole artery 3 3 6
Secondary branch 1 0 1
Morphology NS
Saccular 25 6 31
Fusiform 7 1 8









Calciﬁed 21 8 29
Noncalciﬁed 15 4 19
Maximum
diameter, cm
1.4 6 0.1 2.1 6 0.2 1.5 6 0.1 <.001
NS, Not signiﬁcant.
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the study, leaving only “true” RAAs for the analysis.
Charts of patients with true RAAs were reviewed for
demographic information, clinical presentation, diagnostic
technique, risk factors and comorbidities, perioperative
data, operative data, pathology, and early and long-term
outcomes. Aneurysm characteristics previously published
in RAA studies that have been found to be signiﬁcant
were recorded, including location, morphology, maximum
diameter, number of efferent branches, and calciﬁcation.
Aneurysms that were surgically repaired were classiﬁed
as resection with primary repair, resection with patch, plica-
tion, ex vivo/complex repair, and nephrectomy (planned
or unplanned). In patients followed by observation, serial
images were analyzed for growth, intraluminal thrombus,
or occlusion when available. The UCLA Institutional Re-
view Board approved the database and study methods.
Statistics. All data were managed and retained in a
Microsoft Excel (Version 14; Microsoft Corp, Redmond,
Wash) database. Analysis was performed with the use of
SPSS Statistics for Mac (Version 20.0; IBM Corp, Armonk,
NY). Categorical variables are presented by frequency and
percentage of study population; continuous variables are
presented as mean 6 standard error of mean (SEM), unless
noted otherwise. Differences and level of signiﬁcance be-
tween groups for categorical variables were determined
with the use of the c2 test and Fisher exact test. Differences
between continuous variables were analyzed with the use of
the independent t-test or Mann-Whitney U test. Aneurysm
growth rate was calculated for all patients with two or more
imaging studies. If more than two imaging studies were
available, a weighted average was used to calculate the
overall change in aneurysm size per unit time. A value of
P < .05 was considered signiﬁcant.
RESULTS
Patient demographics and comorbidities. Between
2002 and 2012, 59 RAAs were identiﬁed in 40 patients
at the UCLA Medical Center. Twenty-three women and
17 men had a mean age at diagnosis of 566 2 years (range,
16-78), with comorbidities including hypertension, active
or history of smoking, hypercholesterolemia, diabetes
mellitus, and coronary artery disease (Table I). Two pa-
tients had Marfan syndrome (5%), no patients had docu-
mented chronic obstructive pulmonary disease, and no
patients had documented impaired renal function at the
time of diagnosis.
Twenty-nine patients (73%) were asymptomatic,
whereas 11 patients (27%) presented with renal symptoms.
Patients presented with hematuria, difﬁcult-to-control hy-
pertension, abdominal pain only, ﬂank pain only, and
both abdominal and ﬂank pain (Table I). The mean systolic
blood pressure at presentation was 136 6 3 mm Hg SEM,
and the mean diastolic blood pressure was 83 6 2 mm Hg
SEM. No patient presented with acute rupture. Computed
tomography without contrast was the most frequently used
imaging modality for diagnosis of RAA (n ¼ 16; 40%);
computed tomography angiography was the next mostfrequent (n ¼ 11; 28%), followed by magnetic resonance
angiography (n ¼ 8; 20%), ultrasound (n ¼ 3; 8%), catheter
angiogram (n ¼ 1; 3%), and unknown (n ¼ 1; 3%). Six
patients had concomitant extrarenal aneurysms, the most
common site being the splenic artery.
Aneurysm characteristics. Characteristics of all RAAs
that were evaluated are shown in Table II. The majority of
aneurysms were saccular in shape (n ¼ 31; 53%), rather
than fusiform (n ¼ 8; 14%) or bilobed (n ¼ 5; 8%); the
shape of the remaining aneurysms was not documented
(n ¼ 15; 25%). Aneurysms originated from the main renal
Initial Evaluation
40 Patients
59 Renal Artery Aneurysms (RAA)
Mean diameter: 1.5 .1 cm
Range: 0.5 – 3.0 cm
Symptomatic
11 Patients, 18 RAA
Mean diameter: 1.3 .1 cm
Range: 0.5 – 2.3 cm
Asymptomatic
29 Patients, 41 RAA
Mean diameter: 1.6 .1 cm
Range: 0.6 – 3.0 cm
Observation
4 Patients, 10 RAA
Mean diameter: 1.1 .1 cm
Range: 0.5 – 1.6 cm
Mean follow-up: 10 1 mo.
Range: 1 – 12 mo.
Operative Repair
7 Patients, 8 RAA
Mean diameter: 1.7 .1 cm
Range: 1.0 – 2.3 cm
Observation
21 Patients, 33 RAA
Mean diameter: 1.4 .1 cm
Range: 0.6 – 2.6 cm
Mean follow-up: 46 12 mo.
Range: 1 – 184 mo.
Operative Repair
8 Patients, 8 RAA
Mean diameter: 2.4 .1 cm
Range: 2.0 – 3.0 cm
Fig 1. Treatment used for patients with renal artery aneurysms (RAAs).
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branch (10%), a pole artery (10%), a secondary branch
(2%), and other/unknown (7%). Among operative aneu-
rysms, 56% originated at the renal artery bifurcation, 19%
from a pole artery, 13% from the main trunk, 13% from a
primary branch, and none from a secondary branch. The
location of operative aneurysms did not differ from the
location of nonoperative aneurysms. The average number
of efferent branches from the RAA was 1.8 6 0.12 (range,
0-3), with no signiﬁcant difference between operative and
nonoperative aneurysms (P ¼ .15). Half of all RAAs were
unilateral (51%), and more than half of all RAAs were
located on the right side (58%). There were fewer aneu-
rysms with documented calciﬁcation (n ¼ 19; 32%) than
noncalciﬁed aneurysms (n ¼ 40; 68%).
The mean diameter of all RAAs was 1.5 6 0.1 cm. Sur-
gically treated RAAs were signiﬁcantly larger than those
observed (2.1 6 0.2 cm vs 1.4 6 0.1 cm; P < .001),
and asymptomatic RAAs were signiﬁcantly larger than
symptomatic RAAs (1.6 6 0.1 cm vs 1.3 6 0.1 cm; P ¼
.041). Eight patients (14%) had aneurysms that contained
mural thrombus, six patients (10%) had aneurysms that
were associated with ipsilateral ﬁbromuscular dysplasia,
and four patients (7%) had aneurysms that were associated
with ipsilateral renal artery stenosis.
Treatment. Sixteen RAAs were repaired surgically,
whereas 43 were followed by means of observation
(Fig 1). Eight asymptomatic aneurysms (20%) were
repaired and 33 asymptomatic aneurysms (80%) were not
repaired. Asymptomatic RAAs that were repaired had a
mean diameter of 2.4 6 0.1 cm, with a range of 2.0 to
3.0 cm. No asymptomatic aneurysm <2.0 cm was repaired.
Symptomatic aneurysms that were repaired had a mean
diameter of 1.7 6 0.1 cm, with a range of 1.0 to 2.3 cm.
Ten symptomatic RAAs in four patients were not surgically
repaired. Overall, symptomatic aneurysms that were not
repaired had an average diameter of 1.1 6 0.1 cm, with a
range of 0.5 to 1.6 cm.Technique. Six RAAs were repaired with vein patch
(38%), four with prosthetic patch (25%), three with primary
repair (19%), one with plication (6%), one with patch and
implantation (6%), one with ex vivo repair (6%), and
none required either planned or unplanned nephrectomy.
Outcomes and follow-up data. The median length of
hospital stay for operative patients was 4 days. Perioperative
complications occurred in three patients (20%). One patient
had transient renal insufﬁciency, one patient had an inci-
sional neuroma, and one patient had a self-limited cardiac
arrhythmia. No patients had late postoperative complica-
tions, and the 30-day mortality rate was 0%. All patients
presenting with symptomatic RAAs had resolution of
symptoms after surgery. Of the 14 patients who had hyper-
tension before operation, 1 patient was cured, 3 patients
showed improvement in control of their hypertension
(deﬁned as a decrease$15 mmHg or a decrease in number
of antihypertensive medications), and 9 had no change. The
number of antihypertensive medications taken was the same
before and after surgery (mean ¼ 2). The average blood
pressures before and after surgery were not signiﬁcantly
different (138/86 before surgery, 138/84 after surgery).
In aneurysms that were not surgically repaired, serial
imaging was performed at a mean of 17 6 3 months be-
tween imaging studies. For all except two aneurysms, the
imaging modality used at diagnosis was the same as that
used for serial imaging. Two aneurysms were diagnosed
by computed tomography angiography and followed seri-
ally by magnetic resonance imaging; therefore, for the
calculation of growth rate, only magnetic resonance images
were used to reduce variability because of difference in im-
aging modalities. The overall growth rate, calculated from
14 RAAs with two or more imaging studies available, was
0.60 6 0.16 mm/y (Fig 2). Eleven of the 14 aneurysms
were calciﬁed and had a growth rate of 0.68 6
0.19 mm/y compared with the 0.446 0.24 mm/y growth
rate of the three noncalciﬁed aneurysms (P ¼ .567). Nearly
all of the 12 asymptomatic RAAs with imaging showed
Fig 2. Aneurysm growth in patients treated nonsurgically. RAA,
Renal artery aneurysm.
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eurysms grew. There was no late acute complication for
any aneurysm managed with observation, and the mean
length of follow-up was 36 6 9 months.DISCUSSION
This retrospective study describes the clinical presenta-
tion, management, and long-term outcomes of RAAs at
a large university medical center over a contemporary
10-year period from 2002 to 2012. It demonstrates that
asymptomatic RAAs rarely rupture (in our experience,
none ruptured) and have a very slow growth rate. The
benign natural history in our series suggests that the cur-
rent recommended treatment of asymptomatic RAAs,
with repair at 2 cm, may be too aggressive.
The largest experience with RAA treatment, reported
by Henke et al, studied 168 patients with 252 aneurysms
over a time period of 35 years, from 1965 to 2000.9 In
this study, 55% of patients were asymptomatic, 19% had
bilateral RAAs, and 79% were saccular. Three patients in
this study presented with acute RAA rupture. Compared
with the Henke et al study, our patient group had a higher
incidence of asymptomatic presentation (73%), which is
consistent with the rise in routine use of abdominal imag-
ing in the past few decades. A more contemporary study by
Morita et al looked at RAAs presenting from 1989 to 2009
and similarly showed an increased incidence of asymptom-
atically presenting RAAs of 70%10; more patients in our
group presented with bilateral RAAs (49%) and fewer of
our patients presented with saccular aneurysms (53%).
Treatment of patients in our study was based on cur-
rent recommended guidelines but was modiﬁed by the in-
dividual clinician’s expertise, taking into account patient
presentation and comorbidities, as well as aneurysm charac-
teristics such as calciﬁcation and size stability over time.
Consistent with current guidelines, no asymptomatic
aneurysm <2 cm in diameter was surgically repaired in
this series. However, contrary to current recommenda-
tions, three asymptomatic aneurysms >2 cm were not sur-
gically repaired. Two of these aneurysms were 2.1 cm, and
one was 2.6 cm. Each of these aneurysms had been stablein size for at least 1 year and up to 5 years. The surgeon and
patient decided together to continue serial imaging with
consideration of surgical repair if size increased or if the
aneurysm became symptomatic. Also, against the current
recommendations, 10 symptomatic RAAs in four patients
were not repaired. The patient with six RAAs who presented
with difﬁcult-to-control hypertension and ﬁbromuscular
dysplasia with multiple stenoses underwent balloon angio-
plasty of the renal arteries in an attempt to control the
hypertension. In the patient with hematuria and a 1.2-cm
calciﬁed aneurysm, the surgeon concluded that because
of the aneurysm calciﬁcation, it was probably an old aneu-
rysm and could be followed with annual imaging. In the
patient with two RAAs that were found during workup of
microscopic hematuria, the surgeon thought that at
maximum diameters of 1.1 cm and 1.2 cm in a patient
with well-controlled hypertension, the aneurysms could
safely be followed with annual imaging. In the patient
with abdominal pain, well-controlled hypertension, and a
1.5-cm aneurysm, the surgeon thought that because of
the aneurysm location, the patient was not a candidate for
endovascular repair and would be at signiﬁcant risk of losing
a kidney if surgical repair were pursued. A computed
tomography angiography in 1 year was recommended to
observe for change in size. Despite the fact that the current
recommendation was to surgically repair these aneurysms,
none of these nonsurgically treated patients had develop-
ment of progressive renal symptoms, and none of the aneu-
rysms developed an acute complication. These experiences
support the proposition that current recommendations for
repair are too aggressive.
Many studies have shown a low morbidity and mortal-
ity for surgical repair of RAAs when performed by well-
trained surgeons.9,11-14 The Henke et al study showed
excellent outcomes, with perioperative complications in
only ﬁve patients, technical abnormalities requiring further
intervention in seven patients, long-term complication of
renal failure requiring hemodialysis in only one patient,
and no deaths in patients undergoing surgery.9 Henke
et al also reported a signiﬁcant decrease in blood pressure
and the number of antihypertensive medications in patients
who underwent surgical repair. Recently, endovascular
repair of RAAs has emerged as an alternative to open sur-
gical repair, allowing patients who previously would have
been considered poor surgical candidates to undergo a
less invasive treatment. Although most reports of endovas-
cular repair of RAAs have been case studies or small series,
good results have been obtained with endovascular treat-
ment, whether by embolization or stenting, when cases
have been carefully selected.7,15-19 No patients in our study
underwent endovascular repair, but we are increasingly
considering endovascular repair as an alternative in high-
risk patients and those who are reluctant to undergo a sur-
gical procedure.
English et al reported a perioperative mortality rate
of only 1.7% in 62 patients with 72 RAAs.14 Our study re-
ports no mortalities, low morbidity, and no unplanned ne-
phrectomies; however, we did not ﬁnd a signiﬁcant
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only 29%of patients showed improvement in blood pressure,
whereas the remainder of patients had no change.
Traditionally, indication for repair of an asymptomatic
RAA is to prevent rupture. Studies have reported rupture
rates of 0% to 14%, but most authors agree that the true
rate is approximately 3%.1,3,4,8,20-22 Three ruptures
(1.2%) occurred in the Henke et al group, whereas
Tham et al followed 83 RAAs for a mean of 4.3 years
with no ruptures.8,9 In another study, no ruptures were
observed in 21 patients over an average of 3 years.23 Our
results, with no ruptures, add to this body of literature
and conﬁrm that rupture is an exceedingly rare occurrence.
Aneurysm size is used as a major factor to guide clinical
decision-making; calciﬁcation of the arterial wall is an aneu-
rysm characteristic that has also been used because calciﬁca-
tion has been proposed to be a protective factor against
rupture.4,5 Harrow et al showed 15 of 18 ruptured aneu-
rysms to be noncalciﬁed, and Hidai et al showed that
14% of noncalciﬁed aneurysms ruptured.20,24 However,
conclusive evidence that the presence of calciﬁcation, as
well as the degree of calciﬁcation, affects the risk of aneu-
rysm rupture is lacking.4 In our study, we found no signif-
icant difference in the growth or rupture rates of calciﬁed
and noncalciﬁed aneurysms.
The growth rate of asymptomatic RAAs has, to our
knowledge, not previously been published; therefore, this
study is the ﬁrst to quantify the growth rate of RAAs.
Our study found a growth rate of 0.60 6 0.16 mm/y,
but not all patients who were observed underwent annual
imaging, and therefore the calculated growth rate was
based on only 14 aneurysms. Furthermore, although three
aneurysms >2 cm were followed nonsurgically, only one
had multiple imaging studies. A larger sample with more
frequent imaging is necessary to calculate a reliable growth
rate. On the basis of our experience with aneurysm growth,
it is not surprising that many other studies that have fol-
lowed nonsurgical RAAs have observed a relatively stable
size over years. On the basis of this calculated growth
rate, >50% of the asymptomatic aneurysms in our study
would not require surgical repair in the next 10 years if cur-
rent guidelines for repair are used, and if the size threshold
were increased, very few patients would require surgical
repair during their expected lifespan.
Aneurysm morphology could not be identiﬁed in every
case; however, RAAs frequently occurred at bifurcations
and were saccular. These morphologic ﬁndings inﬂuence
the type of repair and mandate surgical skill to avoid injury
to branch vessels.
The high number of incidentally found asymptomatic
RAAs suggests that the true incidence of RAAs may be
higher than reported in most clinical series, but we were
unable to determine risk factors to help screen patients
who are likely to have RAAs. Because we had no ruptures,
we were also unable to identify factors that are associated
with aneurysm rupture.
One of the main limitations of this study is that it only
included a small number of patients from a single tertiarycare medical center. Although 59 aneurysms were identiﬁed
in 40 patients, imagingmodalities that were used in the diag-
nosis, management, and observation of these aneurysms var-
ied by the preferences of referring physicians and the
consulting vascular surgeon. To better deﬁne the growth
rate, risk of rupture and long-term outcomes of asymptom-
atic RAAs, a larger study with observation of the natural his-
tory of aneurysms >2 cm will be required.
CONCLUSIONS
This contemporary series reveals that asymptomatic an-
eurysms rarely rupture and have a slow growth rate. There
were no adverse outcomes in asymptomatic aneurysms
>2 cm that were observed, despite current recommenda-
tions suggesting surgical repair. Although our numbers are
small, these results suggest that the current recommenda-
tions for the surgical repair of asymptomatic RAAs may be
too aggressive, and thus, further investigation is warranted.
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the natural history and risk of rupture of a renal artery aneurysm is
uncertain. In the largest series in the literature from the University
of Michigan, out of 252 renal artery aneurysms, only three rup-
tures were recorded. Other series have reported the rate of rupture
to be 0% to 14%, but most report rupture rates less than 5%. Tradi-
tionally, indications for repair have focused on the prevention of
rupture. This has resulted in the recommendation of repair for
renal artery aneurysms >2 cm based really on very little data. In
today’s presentation, Dr Lawrence and his colleagues at UCLA
provide additional information regarding the risk of rupture of a
renal artery aneurysm with a focus on the size of the aneurysm
as an indication for repair. Over a 10-year period at UCLA, 40 pa-
tients with 59 renal artery aneurysms were treated. The majority of
patients were asymptomatic, with only 27% displaying symptoms
known to be associated with the aneurysm. Sixteen aneurysms
were repaired, all with diameters greater than 2 cm. Most of the
patients who underwent repair were asymptomatic. At a mean
length of follow-up of 3 years, in patients in whom the aneurysm
was not repaired, no ruptures occurred. Their conclusion: the
criteria of repair for a renal artery aneurysm greater than 2 cm
may be too aggressive.
To begin the discussion of this thought-provoking paper, I
have three questions. First, one of the concerns I have with this
recommendation is that not all renal artery aneurysms are the
same. A 2-cm renal artery aneurysm of the main renal artery may
not be the same as a 2-cm aneurysm of a branch vessel. In your pa-
per, you make no distinction in the size of the aneurysm with
regards to the renal branch involved. Do you think the rupture
risk is equivalent between the two? Should the location of the
aneurysm as well as the size be considered when contemplat-
ing repair? Second, how would you factor age into yourrecommendation? There is evidence to suggest particularly in the
premenopausal female that risk of rupture is greater. That certainly
has been our experience at USC. Should the threshold for repair be
dependent on other factors including age, sex, presence of hyper-
tension and menopause status? Finally, if 2 cm is too small, then
what would be your threshold for repair based on size? Should it
be 2.5 cm, 3 cm? In general, I agree with your recommendation
with regard to size and indication for operation, but as with
most things in medicine, it is difﬁcult to draw distinct lines, and in-
dividual patient factors are probably more important than size
alone.
Ms Jill Q. Klausner. Dr Weaver brings up three excellent
points. Because our series included no ruptured aneurysms, it is
not possible for us to make conclusions regarding the effect of
location, age, gender, menopause status, or presence of hyperten-
sion on rupture risk. We found no statistically signiﬁcant difference
in the location of operative versus nonoperative aneurysms, sug-
gesting that location is not currently being used as the basis for
treatment decisions. Only one patient in our series was a female
of child-bearing age, and her aneurysm was surgically repaired
based on established guidelines to repair renal aneurysms of
women of child-bearing age. The largest renal aneurysm series,
from the University of Michigan, has shown that repair of renal ar-
tery aneurysms is associated with decreased blood pressure, but our
smaller series did not ﬁnd a similar effect. We agree that size
greater than 2 cm should not be the only indication for repair.
We also recognize the complexity of this issue and the multiple fac-
tors that should enter into a decision about renal artery aneurysm
repair, and we are currently conducting a large multi-institutional
trial to determine speciﬁc risk factors for aneurysm growth and
rupture, as well as a speciﬁc threshold for repair, based on size, if
such a recommendation is warranted.
